Safety of Org 34517 900 mg in Patients Who Received Org 34517 in a Previous Trial (Study 28133/P05842)

NCT00844922 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
16
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Merck Sharp & Dohme LLC